NASDAQ: CRDFCardiff Oncology Inc Stock Ownership - Who owns Cardiff Oncology?
Insider buying vs selling
Have Cardiff Oncology Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Gary W. Pace | Director | 2025-07-30 | 275,000 | $2.45 | $673.75kBuy |
| Gary W. Pace | Director | 2025-07-30 | 15,000 | $2.45 | $36.75kBuy |
| James E. Levine | Chief Financial Officer | 2024-12-18 | 2,400 | $5.00 | $12.00kBuy |
| James E. Levine | Chief Financial Officer | 2024-12-17 | 2,752 | $5.42 | $14.90kBuy |
| James E. Levine | Chief Financial Officer | 2024-12-16 | 2,564 | $3.83 | $9.82kBuy |
| Renee P. Tannenbaum | Director | 2024-12-12 | 10,000 | $3.42 | $34.22kBuy |
| Gary W. Pace | Director | 2024-12-11 | 11,500 | $2.60 | $29.90kBuy |
| Gary W. Pace | Director | 2024-12-11 | 350,115 | $2.60 | $910.30kBuy |
CRDF insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CRDF insiders and whales buy or sell their stock.
CRDF Shareholders
What type of owners hold Cardiff Oncology Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Robert Merrill Hunter | 7.52% | 5,065,004 | $10.79M | Insider |
| Blackrock Inc | 5.92% | 3,985,536 | $8.49M | Institution |
| Vanguard Group Inc | 5.33% | 3,588,933 | $7.64M | Institution |
| Ra Capital Management LP | 4.88% | 3,290,000 | $7.01M | Insider |
| Gary W. Pace | 4.64% | 3,124,113 | $6.65M | Insider |
| Bridger Management LLC | 4.41% | 2,968,115 | $6.32M | Insider |
| Laurion Capital Management LP | 3.66% | 2,465,872 | $5.25M | Institution |
| Pfizer Inc | 3.58% | 2,411,575 | $5.14M | Institution |
| Blair William Co | 3.29% | 2,213,606 | $4.71M | Institution |
| Acorn Capital Advisors LLC | 2.91% | 1,962,084 | $4.18M | Institution |
CRDF vs Biotech Stocks
Cardiff Oncology Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.